Sakar Healthcare Reports Rs 11.30 Crore Q2 Profit with 51.9% Revenue Growth
Sakar Healthcare reported a consolidated net profit of Rs 11.30 crore for the September quarter, up from Rs 4.54 crore in the same period last year. Revenue increased by 51.9% to Rs 87.41 crore, driven by new oncology approvals, strong demand across markets, a better oncology product mix, operating leverage, and disciplined cost management. Managing Director Sanjay Shah highlighted significant progress in regulatory approvals, technology transfers, and global market access during the quarter.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 36/100.
Outlets measured: freepressjournal, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–74/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 23 Oct, 05:15 pm. Other outlets followed.
- 1